Analysis of the experience and procedural complications of trans-radial access versus transfemoral access forhepatic arterial perfusion chemotherapy in patients with advanced hepatic malignancies:a retrospective study  

作　　者：吕天野 LYU Tianye(Dept Intervent Therapy,Tianjin Med Univ Cancer Instit&Hosp,Natl Clin Res Cancer Center,Tianjin's Clin Cancer Res Center,Key Lab,Cancer Prev&Therapy,Tianjin 300060)

机构地区：[1]Dept Intervent Therapy,Tianjin Med Univ Cancer Instit&Hosp,Natl Clin Res Cancer Center,Tianjin's Clin Cancer Res Center,Key Lab,Cancer Prev&Therapy,Tianjin 300060

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第2期108-109,共2页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To analyze the differences between transradial access(TRA)and trans-femoral access(TFA)in hepatic arterial perfusion chemotherapy(HAIC)in terms of patient experience,postoperative complications,and patient preferences;explore whether TRA in HAIC is associated with better patient experience and compliance;and determine whether it is safer than TFA.Methods The study was a retrospective cohort study of patients with advanced hepatocellular carcinoma and liver metastases from colorectal cancer treated with HAIC.We enrolled a total of 91 patients with advanced liver malignancies treated with HAIC from November 2022 to May 2023 in the Department of Interventional Therapy and Hepatobiliary Medicine at Tianjin Medical University Cancer Hospital.The patients were divided into three groups:group TRA(n=20,receiving TRA HAIC only),group TFA(n=33,receiving TFA HAIC only),and crossover group[n=19,receiving TFA HAIC(Cross-TFA group)first,followed by TRA HAIC(Cross-TRA group)].

关 键 词：PATIENTS HEPATIC CHEMOTHERAPY 

分 类 号：R735.7[医药卫生—肿瘤]